<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Korean Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JKMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Korean Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8934</issn>
      <issn pub-type="epub">1598-6357</issn>
      <publisher>
        <publisher-name>The Korean Academy of Medical Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26839483</article-id>
      <article-id pub-id-type="pmc">4729509</article-id>
      <article-id pub-id-type="doi">10.3346/jkms.2016.31.2.275</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
          <subj-group subj-group-type="subheading">
            <subject>Obstetrics &amp; Gynecology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Estrogen-mediated Height Control in Girls with Marfan Syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-7540-0522</contrib-id>
          <name>
            <surname>Lee</surname>
            <given-names>Dong-Yun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-3877-252X</contrib-id>
          <name>
            <surname>Hyun</surname>
            <given-names>Hye Sun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huh</surname>
            <given-names>Rimm</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Dong-Kyu</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Duk-Kyung</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoon</surname>
            <given-names>Byung-Koo</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-5265-4749</contrib-id>
          <name>
            <surname>Choi</surname>
            <given-names>DooSeok</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Address for Correspondence: DooSeok Choi, MD. Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea. Tel: +82.2-3410-3514, Fax: +82.2-3410-0630, <email>dooseok.choi@samsung.com</email></corresp>
        <fn id="FN1" fn-type="equal">
          <p><sup>*</sup>Dong-Yun Lee and Hye Sun Hyun contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <volume>31</volume>
      <issue>2</issue>
      <fpage>275</fpage>
      <lpage>279</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>09</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 The Korean Academy of Medical Sciences.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>This study evaluated the efficacy of a stepwise regimen of estradiol valerate for height control in girls with Marfan syndrome. Eight girls with Marfan syndrome who had completed estrogen treatment for height control were included. Estradiol valerate was started at a dose of 2 mg/day, and then was increased. The projected final height was estimated using the initial height percentile (on a disease-specific growth curve for Korean Marfan syndrome [gcPFHt]), and the initial bone age (baPFHt). After the estrogen treatment, the projected final height was compared to the actual final height (FHt). The median baseline chronological and bone age were 10.0 and 10.5 years, respectively. After a median of 36.5 months of treatment, the median FHt (172.6 cm) was shorter than the median gcPFHt (181.0 cm) and baPFHt (175.9 cm). In the six patients who started treatment before the age of 11 years, the median FHt (171.8 cm) was shorter than the median gcPFHt (181.5 cm) and baPFHt (177.4 cm) after treatment. The median differences between the FHt and gcPFHt and baPFHt were 9.2 and 8.3 cm, respectively. In two patients started treatment after the age of 11, the differences between FHt and gcPFHt, and baPFHt after treatment were -4 and 1.4 cm, and -1.2 and 0 cm for each case, respectively. A stepwise increasing regimen of estradiol valerate may be an effective treatment for height control in girls with Marfan syndrome, especially when started under 11 years old.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Graphical Abstract</title>
        <p>
          <graphic xlink:href="jkms-31-275-abf001.jpg" position="float" orientation="portrait"/>
        </p>
      </abstract>
      <kwd-group>
        <kwd>Marfan Syndrome</kwd>
        <kwd>Tall Stature</kwd>
        <kwd>Estradiol Valerate</kwd>
        <kwd>Height Control</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Marfan syndrome is an autosomal dominant connective tissue disorder characterized by a mutation in the fibrillin I gene (<xref rid="B1" ref-type="bibr">1</xref>). Its prevalence is approximately 2-3 per 10,000 individuals (<xref rid="B1" ref-type="bibr">1</xref>). The phenotype of Marfan syndrome varies widely to include many organs including the eyes, heart, aorta, skeleton, skin, and lung (<xref rid="B2" ref-type="bibr">2</xref>).</p>
      <p>Two common features of Marfan syndrome include excessive linear growth and tall stature. Excessive linear growth starts prenatally. Patients with Marfan syndrome then have an earlier, and more rapid puberty-associated growth spurt compared to the general population (<xref rid="B3" ref-type="bibr">3</xref>). This rapid growth is of clinical concern because it can aggravate aortic dilatation (<xref rid="B4" ref-type="bibr">4</xref>) and is also associated with a high prevalence of scoliosis development (<xref rid="B5" ref-type="bibr">5</xref>). Excess growth can also impair physical and psychological well-being in affected adolescents and adults. Therefore, it is necessary to seek methods by which this growth can be controlled.</p>
      <p>Treatment with high dose estrogen has been shown to slow linear growth in constitutionally tall girls (<xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref>). Similarly, efforts have been made to control linear growth using sex steroids in Marfan syndrome. However, there are limited published data regarding height control with high dose estrogen in Marfan syndrome (<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref><xref rid="B11" ref-type="bibr">11</xref><xref rid="B12" ref-type="bibr">12</xref>), and ethinyl estradiol was used in most studies. Although the types and doses of estrogens vary in the literature (<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref><xref rid="B12" ref-type="bibr">12</xref>), 50-300 &#xB5;g of ethinyl estradiol per day is commonly used for height control in girls with Marfan syndrome (<xref rid="B11" ref-type="bibr">11</xref><xref rid="B12" ref-type="bibr">12</xref>). Unfortunately, however, ethinyl estradiol has a strong metabolic effect. Therefore, there are some concerns regarding its use, especially at high doses. Estradiol valerate is more physiologic than is ethinyl estradiol (<xref rid="B13" ref-type="bibr">13</xref>). In addition, ethinyl estradiol is only available in combination with progestin in Korea.</p>
      <p>The aim of this study was to evaluate the efficacy of a stepwise increasing regimen of estradiol valerate for height control in girls with Marfan syndrome.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>MATERIALS AND METHODS</title>
      <sec>
        <title>Patients</title>
        <p>Patients who were diagnosed with Marfan syndrome according to the revised Ghent criteria (<xref rid="B14" ref-type="bibr">14</xref>) and who had visited an adolescent gynecologic clinic at Samsung Medical Center for height control between October 2004 and May 2014 were considered for inclusion. Patients were excluded if they were still undergoing estrogen treatment, did not reach their final height during the study period, or were lost to follow-up during treatment. Ultimately, eight patients were included in the data analysis.</p>
      </sec>
      <sec>
        <title>Estrogen treatment</title>
        <p>In every case, the decision for treatment was made based on the preferences of the patients, their caregivers, and advice from pediatricians. Before treatment, patients were educated regarding the predicted adult height, expected range of height reduction, and the potential side effects of treatment. The age of treatment initiation was determined on a case-by-case basis at the earliest opportunity when both the patient and parents agreed.</p>
        <p>Initially, estradiol valerate (Progynova&#xAE;, Bayer Schering pharma AG, Berlin-wedding, Germany) was administered orally at a dose of 2 mg/day for 6 months. After the first six months, the dose was increased every 2 months by 2 mg/day. The dose was adjusted until the height increment was &lt;1 cm for 2 months. This final dose was then maintained until the patient reached her final height. Once a patient reached 4 mg/day of estradiol valerate or if breakthrough bleeding occurred, 10 mg/day of oral medroxyprogesterone acetate was added to the treatment regimen for days 1-12 of each calendar month. Addition of progestogen was delayed to allow for normal breast and uterine development. One patient was already Tanner stage 3 at the start of the study. In this case, estradiol valerate was initiated at a dose of 4 mg/day, and then was increased according to the same stepwise schedule. When a girl was suspected to have reached her final height, x-rays were used to confirm fusion of the epiphyseal plate. After this confirmation, the dose of estradiol valerate was gradually reduced. <xref ref-type="fig" rid="F1">Fig. 1</xref> illustrates the treatment schedule.</p>
      </sec>
      <sec>
        <title>Measurements</title>
        <p>A stadiometer was used to measure standing height at the start of the study, and then every two months (GL-310P, G-tech international, Uijungbu, Korea). The Korean Marfan syndrome-specific growth curve (growth curve) (<xref rid="B15" ref-type="bibr">15</xref>) was used to calculate each patient's initial height percentile. The projected final height (PFHt) was estimated by the height at 16 years old using the same baseline percentile on the growth curve, because the height at this age represents the maximum point on the curve (gcPFHt). The PFHt was also estimated using the baseline bone age before estrogen treatment (baPFHt). The final height (FHt) was defined as that when the bone age was at least 15 years old. When a patient had reached her FHt, the difference between the PFHt and FHt was calculated. Tanner staging was used to measure puberty (<xref rid="B16" ref-type="bibr">16</xref>). The initial serum estradiol level was also measured. The Greulich and Pyle method was used to measure bone age before starting treatment and after reaching the final height (<xref rid="B17" ref-type="bibr">17</xref>).</p>
      </sec>
      <sec>
        <title>Ethics statement</title>
        <p>This study protocol was approved by the institutional review board of Samsung Medical Center (IRB No. SMC 2014-06-124). Informed consent was exempted because it was a retrospective review of medical records.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>RESULTS</title>
      <p>The patients' baseline clinical features are shown in <xref ref-type="table" rid="T1">Table 1</xref>. Five of the 8 patients had one or more relatives affected by Marfan syndrome. Seven of the patients had the fibrillin I gene mutation. Six had skeletal problems including scoliosis or chest wall deformities. Seven patients had either aortic root dilatation or ectopia lentis. None of the patients had undergone menarche, and all but one patient were in Tanner stages 1 or 2.</p>
      <p>The changes in height parameters after estrogen treatment are presented in <xref ref-type="table" rid="T2">Table 2</xref>. The median baseline chronological age and bone age were 10.0 (ranged 7Y7M-12Y9M) and 10.5 (ranged 8-13Y) years, respectively. After a median of 36.5 months (ranged 16-55 months) of estrogen treatment, the median FHt (172.6 cm) was shorter than were the median gcPFHt (181.0 cm) and baPFHt (175.9 cm).</p>
      <p>The median chronological age and bone age of patients who began the estrogen treatment before the age of 11 (patient no. 1-6) were 9.8 years (ranged 7Y7M-10Y11M) and 10 years (ranged 8-13Y), respectively. After a median of 41 months (ranged 21-55 months) of treatment, the FHt (median: 171.8, range: 161.5-177 cm) was shorter than were the gcPFHt (median: 181.5, range: 165-185 cm) and baPFHt (median: 177.4 cm, range: 164.8-186.9 cm). The median differences between the FHt and gcPFHt and baPFHt were 9.2 cm (ranged 3.5-15 cm) and 8.3 (ranged -5.2-13.3 cm), respectively. In patients who started treatment after the age of 11 years (patient No. 7 and 8), the differences between FHt and gcPFHt and baPFHt after treatment were -4 and 1.4 cm (patient No. 7) and -1.2 and 0 cm (patient No. 8), respectively.</p>
      <p><xref ref-type="fig" rid="F2">Fig. 2</xref> shows annual percentile change plotted on growth curve. In five patients (patient No. 1-5) who were in 80 or more percentile (median, 85; range, 80-92 percentile) on growth curve before treatment, percentile decreased to 47 percentile in median after treatment. In contrast, in two patients who started treatment after the age of 11 (patient No. 7 and 8), percentile on growth curve did not decrease with estrogen treatment.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>This study evaluated the efficacy of estrogen for height control in girls with Marfan syndrome, and revealed that a stepwise regimen of estradiol valerate may be an effective option. The median difference between the predicted and actual final height after estrogen treatment was 6.0 cm by disease specific growth curve, and 5.2 cm by bone age. In the six girls who started estrogen treatment before the age of 11 years, the median difference was 9.2 cm by disease specific growth curve and 8.3 cm by bone age. These results are similar or more favorable to those of previous studies that compared the heights of treated and untreated girls with Marfan syndrome (<xref rid="B11" ref-type="bibr">11</xref><xref rid="B12" ref-type="bibr">12</xref>).</p>
      <p>In this study, we sought to start estrogen treatment as early as possible. The mean chronological age at treatment initiation was 10 years. The mean final height was 172.6 cm. In two previous studies, the ages at treatment initiation were 12.4 (<xref rid="B11" ref-type="bibr">11</xref>) and 11.4 years (<xref rid="B12" ref-type="bibr">12</xref>). The mean final heights in these studies were 184.1 (<xref rid="B10" ref-type="bibr">10</xref>) and 181.5 cm (<xref rid="B11" ref-type="bibr">11</xref>). The mean final height in our study was shorter than that of other studies. This increased height control may be a result of earlier treatment initiation in our study, compared to in others. Similarly, we found that there was remarkable final height reduction in girls who started treatment before the age of 11; however, those who started after age 11 did not experience any height reduction. This finding is consistent with that of a previous study, which reported that estrogen treatment was effective in four girls who started treatment at a mean age of 10.0 years old (mean final height: 174.3 cm) (<xref rid="B12" ref-type="bibr">12</xref>). In constitutionally tall girls, high dose estrogen treatment is most efficacious for height reduction in the youngest girls (<xref rid="B18" ref-type="bibr">18</xref>). In Marfan syndrome, puberty-associated growth peaks approximately 2.2 years earlier than it does in girls without Marfan syndrome (<xref rid="B3" ref-type="bibr">3</xref>). Given this phenomenon, it seems appropriate to start estrogen treatment before 11 years old in this population. However, since ethnic difference can be important in height growth, further studies are needed to draw a general conclusion about the age at starting estrogen.</p>
      <p>Estradiol valerate was used for height control instead of ethinyl estradiol in this study. Introducing estradiol valerate in a stepwise fashion is also relatively physiologic because it induces secondary sexual characteristics without abruptly exposing the patient to high dose estrogen. Fortunately, there were no severe side effects observed in this study. There is no standard protocol for height control in girls with Marfan syndrome. However, given our results, a stepwise regimen of estradiol valerate may be an attractive option.</p>
      <p>The exact mechanism of estrogen-mediated height control is not fully understood. However, there are two possible mechanisms by which estrogen limits linear growth. Estrogen suppresses somatomedin, thereby reducing the growth-promoting effects of growth hormone (<xref rid="B19" ref-type="bibr">19</xref>). Estrogen also increases the rate of skeletal maturation by acting directly on the epiphyseal cartilage (<xref rid="B20" ref-type="bibr">20</xref>).</p>
      <p>This study has several advantages. For one, both the Marfan specific growth model and bone age were used for evaluation. The Marfan syndrome-specific growth curve is necessary to understand the growth patterns and to predict adult height in Marfan syndrome (<xref rid="B21" ref-type="bibr">21</xref>). Most prior groups used conventional height prediction models based on skeletal age (such as the Tanner Whitehouse and Bayley-Pinneau [<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref><xref rid="B11" ref-type="bibr">11</xref>]) to estimate adult height in girls with Marfan syndrome (<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref><xref rid="B11" ref-type="bibr">11</xref><xref rid="B12" ref-type="bibr">12</xref>). However, because these models are based on growth data derived from normal children, their precision may be low in patients with growth abnormalities, such as those with Marfan syndrome (<xref rid="B11" ref-type="bibr">11</xref>). This study is also advantageous for its physiologic use of a stepwise regimen of estradiol valerate. In addition, this study presents a unique treatment regimen which was not previously reported.</p>
      <p>However, this study has limitations. Marfan syndrome is not a common disease; therefore, we had only a small sample size of patients. Another limitation is that we did not include untreated girls as a control, and for comparison to the treated girls.</p>
      <p>In conclusion, estrogen treatment via a stepwise regimen of estradiol valerate may offer effective height control in girls with Marfan syndrome. This regimen may be more efficacious when it is initiated in girls younger than 11 years old. In the future, large-scale research is warranted to substantiate these findings.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>DISCLOSURE:</bold> The authors have no conflicts of interest to disclose.</p>
      </fn>
      <fn fn-type="participating-researchers">
        <p><bold>AUTHOR CONTRIBUTION:</bold> Study concept and design of article: Lee DY, Hyun HS, Choi D. Data collection and analysis: Lee DY, Hyun HS, Huh R, Choi D. Writing draft: Lee DY, Hyun HS, Choi D. Revision: Lee DY, Hyun HS, Jin DK, Kim DK, Choi D. Approval of final manuscript and agreement of submission: all authors.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Judge</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Marfan&#x2019;s syndrome</article-title>
          <source>Lancet</source>
          <year>2005</year>
          <volume>366</volume>
          <fpage>1965</fpage>
          <lpage>1976</lpage>
          <pub-id pub-id-type="pmid">16325700</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dietz</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Cutting</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Pyeritz</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Maslen</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Corson</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Puffenberger</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Hamosh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nanthakumar</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Curristin</surname>
              <given-names>SM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene</article-title>
          <source>Nature</source>
          <year>1991</year>
          <volume>352</volume>
          <fpage>337</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">1852208</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erkula</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Sponseller</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Pyeritz</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Growth and maturation in Marfan syndrome</article-title>
          <source>Am J Med Genet</source>
          <year>2002</year>
          <volume>109</volume>
          <fpage>100</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">11977157</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vetter</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Mayerhofer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>von Bernuth</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ranke</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Schmaltz</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>The Marfan syndrome--analysis of growth and cardiovascular manifestation</article-title>
          <source>Eur J Pediatr</source>
          <year>1990</year>
          <volume>149</volume>
          <fpage>452</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">2140773</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joseph</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Milner</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Steg</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>MB</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Bowen</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Orthopedic aspects of the Marfan phenotype</article-title>
          <source>Clin Orthop Relat Res</source>
          <year>1992</year>
          <issue>277</issue>
          <fpage>251</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="pmid">1555349</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drop</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>De Waal</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>De Muinck Keizer-Schrama</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Sex steroid treatment of constitutionally tall stature</article-title>
          <source>Endocr Rev</source>
          <year>1998</year>
          <volume>19</volume>
          <fpage>540</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">9793756</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Waal</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Greyn-Fokker</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Stijnen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>van Gurp</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Toolens</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>de Munick Keizer-Schrama</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Aarsen</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Drop</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1996</year>
          <volume>81</volume>
          <fpage>1206</fpage>
          <lpage>1216</lpage>
          <pub-id pub-id-type="pmid">8772601</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reeser</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Heremans</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>van Gelderen</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Reduction of adult height in tall girls</article-title>
          <source>Eur J Pediatr</source>
          <year>1979</year>
          <volume>132</volume>
          <fpage>37</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">499254</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skovby</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>McKusick</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <article-title>Estrogen treatment of tall stature in girls with the Marfan syndrome</article-title>
          <source>Birth Defects Orig Artic Ser</source>
          <year>1977</year>
          <volume>13</volume>
          <fpage>155</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="pmid">196698</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knudtzon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aarskog</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Estrogen treatment of excessively tall girls with Marfan syndrome</article-title>
          <source>Acta Paediatr Scand</source>
          <year>1988</year>
          <volume>77</volume>
          <fpage>537</fpage>
          <lpage>541</lpage>
          <pub-id pub-id-type="pmid">3394507</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rozendaal</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>le Cessie</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wit</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hennekam</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <collab>Dutch Marfan Working Group</collab>
          <article-title>Growth-reductive therapy in children with marfan syndrome</article-title>
          <source>J Pediatr</source>
          <year>2005</year>
          <volume>147</volume>
          <fpage>674</fpage>
          <lpage>679</lpage>
          <pub-id pub-id-type="pmid">16291362</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ucar</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Paterson</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Donaldson</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Ethinyl estradiol treatment for growth limitation in girls with Marfan&#x2019;s syndrome--experience from a single center</article-title>
          <source>Endocr Res</source>
          <year>2009</year>
          <volume>34</volume>
          <fpage>109</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="pmid">19878071</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borgelt</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Martell</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Estradiol valerate/dienogest: a novel combined oral contraceptive</article-title>
          <source>Clin Ther</source>
          <year>2012</year>
          <volume>34</volume>
          <fpage>37</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">22169052</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Paepe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Devereux</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Hennekam</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Pyeritz</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Revised diagnostic criteria for the Marfan syndrome</article-title>
          <source>Am J Med Genet</source>
          <year>1996</year>
          <volume>62</volume>
          <fpage>417</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="pmid">8723076</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kwun</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Isojima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Huh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>SY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disease-specific growth charts of Marfan syndrome patients in Korea</article-title>
          <source>J Korean Med Sci</source>
          <year>2015</year>
          <volume>30</volume>
          <fpage>911</fpage>
          <lpage>916</lpage>
          <pub-id pub-id-type="pmid">26130954</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanner</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Whitehouse</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty</article-title>
          <source>Arch Dis Child</source>
          <year>1976</year>
          <volume>51</volume>
          <fpage>170</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="pmid">952550</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greulich</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Pyle</surname>
              <given-names>SI</given-names>
            </name>
          </person-group>
          <article-title>Radiographic atlas of skeletal development of the hand and wrist based on the brush foundation study of human growth and development initiated by T. Wingate Todd, M.B., Ch.B., F.R.C.S</article-title>
          <source>JAMA</source>
          <year>1950</year>
          <volume>143</volume>
          <fpage>1124</fpage>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuhn</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Blunck</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Stahnke</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wiebel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Willig</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Estrogen treatment in tall girls</article-title>
          <source>Acta Paediatr Scand</source>
          <year>1977</year>
          <volume>66</volume>
          <fpage>161</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="pmid">842338</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wiedemann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Suppression of growth hormone-dependent human serum sulfation factor by estrogen</article-title>
          <source>J Clin Endocrinol</source>
          <year>1972</year>
          <volume>34</volume>
          <fpage>51</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">12332922</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bailey</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cowell</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Estrogen treatment of girls and constitutional tall stature</article-title>
          <source>Pediatr Clin North Am</source>
          <year>1981</year>
          <volume>28</volume>
          <fpage>501</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="pmid">7243375</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lyon</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Preece</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Grant</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Growth curve for girls with Turner syndrome</article-title>
          <source>Arch Dis Child</source>
          <year>1985</year>
          <volume>60</volume>
          <fpage>932</fpage>
          <lpage>935</lpage>
          <pub-id pub-id-type="pmid">4062345</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Schematic treatment schedule. E2V, estradiol valerate.</title>
      </caption>
      <graphic xlink:href="jkms-31-275-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Percentile change on Korean Marfan syndrome-specific growth curve during and after estrogen treatment.</title>
      </caption>
      <graphic xlink:href="jkms-31-275-g002"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <title>Baseline clinical features</title>
      </caption>
      <alternatives>
        <graphic xlink:href="jkms-31-275-i001"/>
        <table frame="hsides" rules="rows">
          <thead>
            <tr>
              <th valign="middle" align="left" rowspan="2" colspan="1">Patient No.</th>
              <th valign="middle" align="center" rowspan="1" colspan="6">Diagnostic data</th>
              <th valign="middle" align="center" rowspan="2" colspan="1">Menarche</th>
              <th valign="middle" align="center" rowspan="2" colspan="1">Tanner stage</th>
              <th valign="middle" align="center" rowspan="2" colspan="1">Serum E2 (pg/mL)</th>
            </tr>
            <tr>
              <th valign="middle" align="center" rowspan="1" colspan="1">Family history</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Aortic root dilatation</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Ectopia lentis</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Fibrillin gene mutation</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Scoliosis</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Chest wall deformity</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="right" rowspan="1" colspan="1">4</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="right" rowspan="1" colspan="1">27</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="right" rowspan="1" colspan="1">10</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="right" rowspan="1" colspan="1">17</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="right" rowspan="1" colspan="1">10</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">6</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N/A</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="right" rowspan="1" colspan="1">10</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">7</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="right" rowspan="1" colspan="1">17</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">8</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="right" rowspan="1" colspan="1">129</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p>E2, estradiol; Y, yes; N, no; N/A, not available.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" orientation="portrait" position="float">
      <label>Table 2</label>
      <caption>
        <title>Height before and after treatment</title>
      </caption>
      <alternatives>
        <graphic xlink:href="jkms-31-275-i002"/>
        <table frame="hsides" rules="rows">
          <thead>
            <tr>
              <th valign="middle" align="left" rowspan="2" colspan="1">Patient No.</th>
              <th valign="middle" align="center" rowspan="1" colspan="2">Chronological age</th>
              <th valign="middle" align="center" rowspan="1" colspan="2">Bone age</th>
              <th valign="middle" align="center" rowspan="1" colspan="2">Ht (cm)</th>
              <th valign="middle" align="center" rowspan="2" colspan="1">gcPFHt (cm)</th>
              <th valign="middle" align="center" rowspan="2" colspan="1">gcPFHt-FHt (cm)</th>
              <th valign="middle" align="center" rowspan="2" colspan="1">baPFHt (cm)</th>
              <th valign="middle" align="center" rowspan="2" colspan="1">baPFHt-FHt (cm)</th>
              <th valign="middle" align="center" rowspan="2" colspan="1">Treatment duration (M)</th>
            </tr>
            <tr>
              <th valign="middle" align="center" rowspan="1" colspan="1">Baseline</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Final</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Baseline</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Final</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Baseline</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">FHt</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">7Y7M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10Y10M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">147</td>
              <td valign="top" align="left" rowspan="1" colspan="1">165.4</td>
              <td valign="top" align="left" rowspan="1" colspan="1">185</td>
              <td valign="top" align="center" rowspan="1" colspan="1">15</td>
              <td valign="top" align="left" rowspan="1" colspan="1">177.5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">12.1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">21</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">9Y2M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16Y1M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">8Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">151.2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">177</td>
              <td valign="top" align="left" rowspan="1" colspan="1">181</td>
              <td valign="top" align="center" rowspan="1" colspan="1">4</td>
              <td valign="top" align="left" rowspan="1" colspan="1">184.2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">7.2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">44</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">9Y8M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">15Y0M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">13Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">18Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">155.8</td>
              <td valign="top" align="left" rowspan="1" colspan="1">170</td>
              <td valign="top" align="left" rowspan="1" colspan="1">181</td>
              <td valign="top" align="center" rowspan="1" colspan="1">11</td>
              <td valign="top" align="left" rowspan="1" colspan="1">164.8</td>
              <td valign="top" align="center" rowspan="1" colspan="1">-5.2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">55</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">9Y8M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16Y6M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">11Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">15Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">156.6</td>
              <td valign="top" align="left" rowspan="1" colspan="1">174.1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">182</td>
              <td valign="top" align="center" rowspan="1" colspan="1">7.9</td>
              <td valign="top" align="left" rowspan="1" colspan="1">177.3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3.2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">35</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10Y2M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">13Y5M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">161.1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">173.6</td>
              <td valign="top" align="left" rowspan="1" colspan="1">184</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10.4</td>
              <td valign="top" align="left" rowspan="1" colspan="1">186.9</td>
              <td valign="top" align="center" rowspan="1" colspan="1">13.3</td>
              <td valign="top" align="left" rowspan="1" colspan="1">38</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">6</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10Y11M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">15Y3M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">147.3</td>
              <td valign="top" align="left" rowspan="1" colspan="1">161.5</td>
              <td valign="top" align="left" rowspan="1" colspan="1">165</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3.5</td>
              <td valign="top" align="left" rowspan="1" colspan="1">170.9</td>
              <td valign="top" align="center" rowspan="1" colspan="1">9.4</td>
              <td valign="top" align="left" rowspan="1" colspan="1">52</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">7</td>
              <td valign="top" align="center" rowspan="1" colspan="1">11Y8M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">14Y8M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">11Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">15Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">158</td>
              <td valign="top" align="left" rowspan="1" colspan="1">173</td>
              <td valign="top" align="left" rowspan="1" colspan="1">169</td>
              <td valign="top" align="center" rowspan="1" colspan="1">-4</td>
              <td valign="top" align="left" rowspan="1" colspan="1">174.4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.4</td>
              <td valign="top" align="left" rowspan="1" colspan="1">28</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">8</td>
              <td valign="top" align="center" rowspan="1" colspan="1">12Y9M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">14Y2M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">13Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">15Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">165</td>
              <td valign="top" align="left" rowspan="1" colspan="1">172.2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">171</td>
              <td valign="top" align="center" rowspan="1" colspan="1">-1.2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">172.2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0</td>
              <td valign="top" align="left" rowspan="1" colspan="1">16</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Median</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10.0Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">14.8Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10.5Y</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16Y</td>
              <td valign="top" align="left" rowspan="1" colspan="1">156.2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">172.6</td>
              <td valign="top" align="left" rowspan="1" colspan="1">181.0</td>
              <td valign="top" align="center" rowspan="1" colspan="1">6.0</td>
              <td valign="top" align="left" rowspan="1" colspan="1">175.9</td>
              <td valign="top" align="center" rowspan="1" colspan="1">5.2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">36.5</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p>Ht, height; FHt, final height; gcPFHt, projected final height by growth curve; baPFHt, projected final height by bone age; FHt, final height; Y, year; M, month.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
